Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0473 per EA under NDC 64380016201. Its NADAC has been published 212 times since Aug 3, 2022.
FDA first approved this application on Oct 31, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380016201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075079FDA Approved
10/31/1997
TE Code
AB
On Market Since
4/4/2022
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 212 times since Aug 3, 2022, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.0765 (Nov 16, 2022) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0498 |
| 52-week low | $0.0455 |
| Median price | $0.0511 |
| Average price | $0.0557 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 212 |
| Tracking since | Aug 3, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Strides Pharma Inc., is $0.0473 per EA (NDC 64380016201), effective Aug 19, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 31.6%. It has been tracked across 212 weekly CMS publications since Aug 3, 2022.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Aug 3, 2022, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.0765 (Nov 16, 2022), with a median of $0.0511 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYBUTYNIN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 64380016201) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.